Finding new synthetic compounds to treat corneal injuries
Official title: Discovery of synthetic flavonoids for the treatment of corneal injury
Funded at University of North Texas Hlth Sci Ctr · NIH-11004327 · Data updated 2026-11-12
This study is looking at new treatments made from natural compounds to help heal corneal injuries and reduce scarring, which could help people avoid surgery and improve their vision.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $185,000 |
| NIH project number | 5R21EY035849-02 |
| Project ID | NIH-11004327 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals suffering from corneal injuries or conditions leading to corneal scarring.
✕Less likely to help
Patients with corneal injuries that are not amenable to pharmacological treatment or those who have already undergone corneal transplantation may not benefit from this research.
What this research studies
This research focuses on developing new synthetic flavonoids to treat corneal injuries, which are a leading cause of blindness. The team will investigate how these compounds can reduce scarring and fibrosis in the cornea, potentially offering a less invasive alternative to corneal transplantation. By synthesizing and testing novel flavonoids, the researchers aim to identify effective treatments that can improve healing and restore vision. Patients may benefit from these new therapies that could mitigate the need for surgery and its associated risks.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option that helps restore vision and reduces the need for corneal transplants.
How similar studies have gone: Previous studies have shown promise with naturally occurring flavonoids in treating corneal fibrosis, suggesting potential success for these novel synthetic compounds.
Where this research is happening
-
University of North Texas Hlth Sci Ctr
Fort Worth, United States Active
Researchers
- Principal investigator: Karamichos, Dimitrios — University of North Texas Hlth Sci Ctr
- Study coordinator: Karamichos, Dimitrios
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.